You are here:
Therapy
292 kb
Novel iron-oxide based Nanoparticles for Treating Hyperphosphatemia | Ref. No.: CH557
S-Oxprenolol for treating amyotrophic lateral sclerosis (ALS) | Ref. No.: CH589223 kb
S-Oxprenolol for treating amyotrophic lateral sclerosis (ALS) | Ref. No.: CH589
Cytokine-Loaded Microparticles in Hyaluronic Acid for Treatment of Osteoarthritis | Ref. No.: CH519202 kb
Cytokine-Loaded Microparticles in Hyaluronic Acid for Treatment of Osteoarthritis | Ref. No.: CH519
Angiotensin 2 Receptor Agonists for Use in Treatment of Cachexia | Ref. No.: CH630207 kb
Angiotensin 2 Receptor Agonists for Use in Treatment of Cachexia | Ref. No.: CH630
Novel method for expansion of human satellite cells and muscle regeneration | Ref. No.: CH721154 kb
Novel method for expansion of human satellite cells and muscle regeneration | Ref. No.: CH721
MCC1 Inhibitors for Restriction of Metastasis and Cancer Progression | Ref. No.: CH713154 kb
MCC1 Inhibitors for Restriction of Metastasis and Cancer Progression | Ref. No.: CH713
Delayed bone fracture healing treatment | Ref. No.: CH592328 kb
Delayed bone fracture healing treatment | Ref. No.: CH592
Novel Imidazol-Based HDAC Inhibitors for the Treatment of Cancer | Ref. No.: CH700207 kb
Novel Imidazol-Based HDAC Inhibitors for the Treatment of Cancer | Ref. No.: CH700
Novel Imidazol-Based HDAC Inhibitors for the Treatment of Cancer | Ref. No.: CH700207 kb
Novel Imidazol-Based HDAC Inhibitors for the Treatment of Cancer | Ref. No.: CH700
250 kb
Novel Peptides for Celiac Disease Diagnosis | Ref. No.: CH462
Cell-based urinary biomarkers for renal transplantation rejection | Ref. No.: CH846237 kb
Cell-based urinary biomarkers for renal transplantation rejection | Ref. No.: CH846
Urinary Calprotectin as Biomarker for intrinsic acute kidney injury | Ref. No.:: CH574287 kb
Urinary Calprotectin as Biomarker for intrinsic acute kidney injury | Ref. No.:: CH574